Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

3D-Printed insoles offer new hope for flat feet sufferers

NCT ID NCT07022093

Symptom relief Sponsor: GÖZDE KESİKBAŞ Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether custom-made insoles, created with 3D printing or computer-controlled machines, can help people with flexible flat feet. Forty adults aged 18 to 55 who had not used custom insoles recently took part. The researchers measured changes in foot pain, disability, and activity levels using a standard questionnaire.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Oct 2024

Finished

Oct 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals aged between 18 and 55 years * Diagnosed with flexible pes planus (flat feet) * No prior use of custom orthotic insoles within the past 6 months * Able to walk independently without assistive devices * Voluntarily agree to participate and provide informed consent Exclusion Criteria: * History of lower limb or foot surgery * Presence of neurological, rheumatologic, or musculoskeletal disorders affecting gait * Presence of severe foot deformities (e.g., rigid pes planus, cavus foot) * Use of medications that affect muscle or joint function * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pes planus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

flatfoot

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pes planus

Contacts and locations

Locations

  • Ondokuz Mayıs University

    Samsun, 55139, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.